Please use this identifier to cite or link to this item:
https://accedacris.ulpgc.es/handle/10553/137156
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Iborra, M. | en_US |
dc.contributor.author | Botella, B. | en_US |
dc.contributor.author | Martín-Arranz, M.D. | en_US |
dc.contributor.author | Ceballos Santos, Daniel Sebastián | en_US |
dc.date.accessioned | 2025-04-22T13:41:40Z | - |
dc.date.available | 2025-04-22T13:41:40Z | - |
dc.date.issued | 2025 | en_US |
dc.identifier.uri | https://accedacris.ulpgc.es/handle/10553/137156 | - |
dc.language | eng | en_US |
dc.publisher | Oxford University Press | en_US |
dc.source | European Crohn’s and Colitis Organization / #P0890: jjae190.1064, pp. 1685-1686 (Febrero 2025) | en_US |
dc.subject | 32 Ciencias médicas | en_US |
dc.subject | 320503 Gastroenterología | en_US |
dc.title | Real-World Outcomes of Upadacitinib in Crohn’s Disease: Insights from ENEIDA database | en_US |
dc.type | info:eu-repo/semantics/conferenceObject | en_US |
dc.type | ConferenceObject | en_US |
dc.relation.conference | 20th European Crohn’s and Colitis Organization Inflammatory Bowel Diseases | en_US |
dc.description.lastpage | 1686 | en_US |
dc.description.firstpage | 1685 | en_US |
dc.investigacion | Ciencias de la Salud | en_US |
dc.type2 | Póster de congresos | en_US |
dc.description.numberofpages | 2 | en_US |
dc.utils.revision | Sí | en_US |
dc.date.coverdate | Febrero 2025 | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.contributor.buulpgc | BU-MED | en_US |
dc.contributor.buulpgc | BU-MED | en_US |
dc.contributor.buulpgc | BU-MED | en_US |
dc.contributor.buulpgc | BU-MED | en_US |
item.fulltext | Sin texto completo | - |
item.grantfulltext | none | - |
crisitem.author.dept | Departamento de Ciencias Médicas y Quirúrgicas | - |
crisitem.author.orcid | 0000-0003-2384-4524 | - |
crisitem.author.fullName | Ceballos Santos, Daniel Sebastián | - |
Appears in Collections: | Póster de congreso |
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.